Stock market
Pharma: Finanzinvestor EQT will Diagnostikkonzern Qiagen übernehmen
Der Pharmadienstleister Qiagen wird von einem schwedischen Finanzinvestor umworben. Der legt ein Angebot für den Dax-Konzern vor.
Related discussion groups
No group discusses this yet. Start a discussion group and attach this story.
More on Stock market
- Iran’s Oil Reserves Run Dry as U.S. Naval Blockade TightensIranian oil in floating storage has been drained amid the U.S. Navy blockade, the Wall Street Journal has reported, citing Kpler data that suggests further tightening in global oil supply. “There’s...
- Seoul stocks slide over 3 pct on profit-taking amid persistent AI woesSEOUL, Oct. 22 (Yonhap) -- South Korean shares plunged more than 3 percent Thurs...
- Borsa: Asia in rosso, nuova pressione sui tecnologiciI future su Wall Street e sull'Europa sono in negativo
- IQM Quantum Computers Announces Conference Call to Report Third Quarter 2026 Financial Results on November 5, 2026ESPOO, Finland — As published previously, IQM Quantum Computers Plc (Nasdaq: IQMX) (“IQM” or the “Company”), a global leader in superconducting quantum computers, will report financial results for...
- Taiwan stocks lower at close of trade; Taiwan Weighted down 1.68%
- India’s Margin-Funded Stock Bets Fall as Small-Cap Rally FaltersLeveraged bets on Indian stocks are heading for their first monthly drop since March, a sign retail traders are cutting risk as the rally in some of the market’s most speculative corners unravels.